Features of monitoring children with juvenile arthritis, who receive genetic engineering biological therapy
The article gives an overview of literature data on the features of prescription and safety of biological agents in treatment of patients with juvenile arthritis. The author analyzed the experience of use of biologics in children with juvenile arthritis. There was noted the need for standardization of monitoring in the process of treatment of patients with juvenile arthritis.